219 related articles for article (PubMed ID: 27203304)
1. Stem cells and uterine leiomyomas: What is the evidence?
Carneiro MM
JBRA Assist Reprod; 2016 Mar; 20(1):33-7. PubMed ID: 27203304
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific stem cells in the myometrium and tumor-initiating cells in leiomyoma.
Ono M; Bulun SE; Maruyama T
Biol Reprod; 2014 Dec; 91(6):149. PubMed ID: 25376230
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
Commandeur AE; Styer AK; Teixeira JM
Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
[TBL] [Abstract][Full Text] [Related]
4. Current understanding of somatic stem cells in leiomyoma formation.
Mas A; Cervello I; Gil-Sanchis C; Simón C
Fertil Steril; 2014 Sep; 102(3):613-20. PubMed ID: 24890270
[TBL] [Abstract][Full Text] [Related]
5. CXCL12 Attracts Bone Marrow-Derived Cells to Uterine Leiomyomas.
Moridi I; Mamillapalli R; Kodaman PH; Habata S; Dang T; Taylor HS
Reprod Sci; 2020 Sep; 27(9):1724-1730. PubMed ID: 32020550
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of the truncated form of High Mobility Group A proteins (HMGA2) in human myometrial cells induces leiomyoma-like tissue formation.
Mas A; Cervelló I; Fernández-Álvarez A; Faus A; Díaz A; Burgués O; Casado M; Simón C
Mol Hum Reprod; 2015 Apr; 21(4):330-8. PubMed ID: 25542836
[TBL] [Abstract][Full Text] [Related]
7. Somatic stem cells in the myometrium and in myomas.
Maruyama T; Ono M; Yoshimura Y
Semin Reprod Med; 2013 Jan; 31(1):77-81. PubMed ID: 23329640
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic and genetic landscape of uterine leiomyomas: a current view over a common gynecological disease.
Laganà AS; Vergara D; Favilli A; La Rosa VL; Tinelli A; Gerli S; Noventa M; Vitagliano A; Triolo O; Rapisarda AMC; Vitale SG
Arch Gynecol Obstet; 2017 Nov; 296(5):855-867. PubMed ID: 28875276
[TBL] [Abstract][Full Text] [Related]
9. Uterine Leiomyoma Stem Cells: Linking Progesterone to Growth.
Bulun SE; Moravek MB; Yin P; Ono M; Coon JS; Dyson MT; Navarro A; Marsh EE; Zhao H; Maruyama T; Chakravarti D; Kim JJ; Wei JJ
Semin Reprod Med; 2015 Sep; 33(5):357-65. PubMed ID: 26251118
[TBL] [Abstract][Full Text] [Related]
10. Ovarian steroids, stem cells and uterine leiomyoma: therapeutic implications.
Moravek MB; Yin P; Ono M; Coon JS; Dyson MT; Navarro A; Marsh EE; Chakravarti D; Kim JJ; Wei JJ; Bulun SE
Hum Reprod Update; 2015; 21(1):1-12. PubMed ID: 25205766
[TBL] [Abstract][Full Text] [Related]
11. Molecular and Cellular Insights into the Development of Uterine Fibroids.
Machado-Lopez A; Simón C; Mas A
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445194
[TBL] [Abstract][Full Text] [Related]
12. Novel therapeutic strategies for leiomyomas: targeting growth factors and their receptors.
Nowak RA
Environ Health Perspect; 2000 Oct; 108 Suppl 5():849-53. PubMed ID: 11035994
[TBL] [Abstract][Full Text] [Related]
13. Possible involvement of inflammatory/reparative processes in the development of uterine fibroids.
Protic O; Toti P; Islam MS; Occhini R; Giannubilo SR; Catherino WH; Cinti S; Petraglia F; Ciavattini A; Castellucci M; Hinz B; Ciarmela P
Cell Tissue Res; 2016 May; 364(2):415-27. PubMed ID: 26613601
[TBL] [Abstract][Full Text] [Related]
14. Stro-1/CD44 as putative human myometrial and fibroid stem cell markers.
Mas A; Nair S; Laknaur A; Simón C; Diamond MP; Al-Hendy A
Fertil Steril; 2015 Jul; 104(1):225-34.e3. PubMed ID: 25989979
[TBL] [Abstract][Full Text] [Related]
15. Serum sestrin 2 levels in patients with uterine leiomyomas.
Kabakci M; Topbas Selcuki NF; Aydin Z; Bagci K; Kaya C; Yalcin Bahat P
J Obstet Gynaecol; 2022 Nov; 42(8):3616-3620. PubMed ID: 36346966
[TBL] [Abstract][Full Text] [Related]
16. Uterine leiomyomas exhibit fewer stem/progenitor cell characteristics when compared with corresponding normal myometrium.
Chang HL; Senaratne TN; Zhang L; Szotek PP; Stewart E; Dombkowski D; Preffer F; Donahoe PK; Teixeira J
Reprod Sci; 2010 Feb; 17(2):158-67. PubMed ID: 19805552
[TBL] [Abstract][Full Text] [Related]
17. New concepts in the treatment of uterine leiomyomas.
Stewart EA; Nowak RA
Obstet Gynecol; 1998 Oct; 92(4 Pt 1):624-7. PubMed ID: 9764641
[TBL] [Abstract][Full Text] [Related]
18. Epigenomic and enhancer dysregulation in uterine leiomyomas.
Mlodawska OW; Saini P; Parker JB; Wei JJ; Bulun SE; Simon MA; Chakravarti D
Hum Reprod Update; 2022 Jun; 28(4):518-547. PubMed ID: 35199155
[TBL] [Abstract][Full Text] [Related]
19. Classical cadherin and catenin expression in normal myometrial tissues and uterine leiomyomas.
Tai CT; Lin WC; Chang WC; Chiu TH; Chen GT
Mol Reprod Dev; 2003 Feb; 64(2):172-8. PubMed ID: 12506349
[TBL] [Abstract][Full Text] [Related]
20. Human uterine leiomyoma stem/progenitor cells expressing CD34 and CD49b initiate tumors in vivo.
Yin P; Ono M; Moravek MB; Coon JS; Navarro A; Monsivais D; Dyson MT; Druschitz SA; Malpani SS; Serna VA; Qiang W; Chakravarti D; Kim JJ; Bulun SE
J Clin Endocrinol Metab; 2015 Apr; 100(4):E601-6. PubMed ID: 25658015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
